ZNRF3 / E3 ubiquitin-protein ligase ZNRF3 · Western blot design guide

Design a Western Blot for ZNRF3

Source-linked ZNRF3 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-ZNRF3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for ZNRF3: expected band ~100.6 kDa, hero antibody A02974-1, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable ZNRF3 Western blot protocol sheet — expected band ~100.6 kDa, antibody A02974-1, controls and PMC citations. Open the full ZNRF3 WB guide →

ZNRF3 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~100.6 kDa
Observed band ~130 kDa
Gel 5–20% (catalog A02974-1)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM Cleaved
Caveat Band identity controls
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Source-Linked ZNRF3 Western Blot Protocol Options

The A02974-1 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman CACO-2, human A549, human Hacat (catalog A02974-1)
Gel %5–20% (catalog A02974-1)
Load30 ug; reducing conditions (catalog A02974-1)
Transfera nitrocellulose membrane at 150 mA for 50-90 minutes (catalog A02974-1)
Membranenitrocellulose membrane (catalog A02974-1)
Blocking5% non-fat milk/TBS for 1.5 hour at RT (catalog A02974-1)
Primary antibodyA02974-1 · 0.5 μg/mL (catalog A02974-1)
Primary incubationovernight at 4°C (catalog A02974-1)
Secondary antibodygoat anti-rabbit IgG-HRP, 1:5000 (catalog A02974-1)
Secondary incubation1.5 hour at RT (catalog A02974-1)
WashTBS-0.1%Tween 3 times with 5 minutes each (catalog A02974-1)
DetectionECL (catalog A02974-1)
Section 2

What Is the Expected ZNRF3 Western Blot Band Size?

ZNRF3 is predicted at 100.6 kDa, but an empirical band appears near 130 kDa; the cause of this difference is not established.

What am I looking at on my blot?
Band near 130 kDaEmpirical ZNRF3 band in reducing whole-cell lysates; its difference from the predicted mass is unexplained.
Band near 100.6 kDaCould match the predicted full-length precursor; confirm its identity.
Band below the precursorCould reflect signal-peptide cleavage; the mature band size is unknown.
Multiple bandsCould involve isoforms 1 and 2; distinct migration is unverified.
💡Expected ZNRF3 appearanceZNRF3 has a predicted precursor mass of 100.6 kDa, while antibody QC reports a band near 130 kDa; the cause of the difference is unknown, so confirm band identity with appropriate controls.
How each factor affects band size
Predicted full-length mass100.6 kDa is the sequence-based precursor mass, not a demonstrated migration position.
Signal peptide at residues 1–55Cleavage could make the mature protein smaller than the precursor; its apparent mass is unknown.
Splice isoform 1May differ in apparent size from isoform 2; no isoform mass is supplied.
Splice isoform 2May differ in apparent size from isoform 1; distinct migration is unverified.
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateLimited recovery of membrane-localized ZNRF3.Check membrane-protein extraction and test a membrane-enriched sample.
Band higher than expectedThe observed 130 kDa band exceeds the 100.6 kDa prediction; the cause is unknown.Compare with the antibody QC pattern and confirm identity by ZNRF3 knockdown.
Band lower than expectedSignal-peptide cleavage or an alternative isoform is possible.Check antibody epitope coverage and confirm the band by ZNRF3 knockdown.
Multiple bandsIsoforms 1 and 2 are annotated, but their migration is unknown.Assess each band with ZNRF3 knockdown and an independent antibody.
Weak or no signalMembrane-localized ZNRF3 may be poorly recovered.Improve membrane-protein extraction and verify sample recovery with a membrane marker.

Sample controls for ZNRF3 Western blot

🧪For positive controls for ZNRF3 in Western blot, you can use no HPA-supported sample because no positive tissue or cell line was supplied.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: HPA provides no sample data, so a tissue-based positive control cannot be selected.

HPA tissue expression evidence for ZNRF3

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced ZNRF3 Western Blot Tips

Deeper troubleshooting and optimisation questions for ZNRF3, answered from its protein features.

How should ZNRF3 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
How could ZNRF3 isoforms affect the bands I detect?
Isoforms · Isoform 2 lacks UniProt residues 1–100 of isoform 1, including its annotated signal-peptide region. An antibody recognizing that region may miss isoform 2. Check the antibody epitope before assigning a smaller band to an isoform; the sequence difference alone does not establish its apparent size.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of ZNRF3?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for ZNRF3 Western blot?
Transfer · ZNRF3 is a single-pass membrane protein, and the supplied observed band is about 130 kDa. Choose transfer conditions that retain and transfer proteins in that size range, then check transfer at about 130 kDa with a total-protein stain.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02974-1 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should ZNRF3 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Why might ZNRF3 appear near 130 kDa instead of 100.6 kDa?
Interpretation · The supplied observed band is about 130 kDa, while the predicted mass is 100.6 kDa. ZNRF3 has a signal peptide at UniProt residues 1–55 and is a single-pass membrane protein, but those features alone do not explain the difference. The supplied features list no glycosylation sites or modified residues, so do not assign the shift to a specific modification.

Use the same sample preparation and membrane-protein recovery approach across samples. ZNRF3 is a cell-membrane protein, so differences in membrane recovery can affect the measured band. Quantify the same validated band and use a loading measure appropriate to the material loaded.

The supplied interaction annotation says RSPO1 promotes ZNRF3 interaction with LGR4 and membrane clearance of ZNRF3. Record RSPO1 exposure and compare matched conditions when interpreting membrane-associated signal. The annotation does not establish a specific Western-blot band change.

First check whether the antibody recognizes UniProt residues 1–100: isoform 2 lacks that region. Compare the band's behavior with the expected membrane-associated signal and validate antibody specificity before assigning it to an isoform. The supplied features do not establish the size or identity of an extra band.
Boster reagents

ZNRF3 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of ZNRF3 using anti-ZNRF3 antibody (A02974-1). Electrophoresis was performed on a 5-20% SDS-PAGE gel at 70V (Stacking gel) / 90V (Resolving gel) for 2-3 hours. The sample well of each lane was loaded with 30 ug of sample under reducing conditions. Lane 1: human CACO-2 whole cell lysates, Lane 2: human A549 whole cell lysates, Lane 3: human Hacat whole cell lysates. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-ZNRF3 antigen affinity purified polyclonal antibody (Catalog # A02974-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for ZNRF3 at approximately 130 kDa. The expected band size for ZNRF3 is at 101 kDa.
Anti-ZNRF3 Antibody Picoband®
Cat # A02974-1

The catalog reports one human-reactive anti-ZNRF3 antibody, A02974-1, with a Western blot image from human CACO-2, A549, and HaCaT whole-cell lysates. The reported band is approximately 130 kDa, versus an expected 101 kDa; the image documents these tested samples only.

Which to pick: A02974-1 is the only listed option and has a Western blot image for human cell lysates. Check whether the reported 130 kDa band, rather than the expected 101 kDa band, fits your assay before interpreting results.

Source: BosterBio ZNRF3 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.